Aletho News


Biden’s New NIH Head Solidify’s America’s Breakaway Health Agency Crisis

By Jefferey Jaxen | May 18, 2023

American health agencies are in a crisis of their own making. The pandemic response has both amplified and spotlighted the classic shortcomings and limitations of agencies like the U.S. Food and Drug Administration (FDA), the Centers for Disease Control and Prevention (CDC), and the National Institutes of Health (NIH).

News this week reports Biden has chosen Dr. Monica Bertagnolli, formerly National Cancer Institute Director, to lead the NIH. Bertagnolli fills the absence left by Dr. Francis Collins.

In a post-Covid world, much of the public-facing legacy of agency directors is written by their actions during the failed pandemic response. History will show it as a doomed era where no leadership escaped without tarnished careers from their unified actions to viciously mandate Covid shots, mask kids, keep schools closed and lockdown society causing irreparable harm to the American economy – all without the science to back up their decisions.

Former NIH head Collins will be forever known as the man who shut down scientific debate at a time when open dialogue about the already known, published research could have saved lives, the economy, and the mental health of our current population. Purposely ignored warnings, which came in the form of the Great Barrington Declaration, that internal emails show Collins and Fauci colluded to publish a ‘devastating takedown’ of its premise using the full weight of their agencies and media power.

Dr. Bertagnolli’s deep funding by Pfizer, and to a lesser extent from Johnson & Johnson subsidiary Janssen, is chronicled by The Daily Signal :

From 2015 through 2021, Bertagnolli received more than 116 grants from Pfizer, totaling $290.8 million. This amount made up 89% of all her research grants, according to Open Payments, a national transparency program under the Center for Medicare & Medicaid Services that collects and publishes information about financial relationships between drug and medical device companies and certain health care providers.

Her extensive background in cancer research and ties to Pfizer and other pharma companies raises questions about the timing of her placement at the head of NIH, the largest  single public funder of biomedical and behavioral research in the world at more than $40 billion.

The Covid vaccine gold rush has come to an end for companies like Pfizer and Moderna. A brief look at headlines tells of the next profit push on the horizon being mRNA cancer vaccine therapies.

Meanwhile, an epidemic surge of cancers of unknown causes is also grabbing headlines.

Bertagnolli appears well-positioned to streamline an injectable pharmaceutical ‘answer’ to a growing cancer question while obscuring further investigation into its root cause(s).

Meanwhile, Walensky’s abrupt departure from a badly damaged CDC has public trust in the agency racing for the doors at breakaway speeds.

The FDA has done no better. After Trump’s director, Stehpan Hahn stepped down as the administration changed hands, Biden kept the agency without a presidential nomination for commissioner for the maximum time allowed by law – nearly one year.

In that time, the FDA pushed through emergency use authorizations for J&J’s Covid shot, expanded Pfizer’s EUA to 12-15 yr-olds and 5-11 yr-old, added EUA booster doses and mishandled massive warnings about increases in myocarditis, Guillain-Barre syndrome and thrombocytopenia after Covid shots. The agency’s authoritarian booster push also saw infighting due to a lack of data to inform the decision culminating in two of the FDA’s top, longtime vaccine regulators [Kruse & Gruber] departing in disgust.

A recent BMJ article titled The decline of science at the FDA has become unmanageable states, … the corruption of the FDA’s scientific culture remains the primary culprit driving the deterioration of safety and effectiveness standards.”

By all measures, America’s health agencies are in rapid decline as a litany of historical issues like Big Pharma’s revolving door influence, an outward mission-directed posture of mandates and censorship, a continued doubling down on bad policy, and an imbalance focusing on liability-free injectable products as the answer has left American marooned.

The path forward for American health, suffering in many categories, has challenges ahead. Yet the many failures and outright censorship of the medical and research communities during the failed pandemic response have created a new space being rapidly populated by medical professionals, experts, and citizen journalists who see the value and desperate need to investigate and report on reality, expose bad science and maximize open debate surrounding key health issues. It is the best of times and it is the worst of times.

May 18, 2023 - Posted by | Corruption, Science and Pseudo-Science | , ,

No comments yet.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: